Chevy Chase Trust Holdings Inc. lifted its stake in shares of Clorox Company (The) (NYSE:CLX) by 0.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 127,573 shares of the company’s stock after purchasing an additional 1,059 shares during the quarter. Chevy Chase Trust Holdings Inc. owned about 0.10% of Clorox worth $16,828,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Shell Asset Management Co. raised its stake in shares of Clorox by 102.5% during the third quarter. Shell Asset Management Co. now owns 119,382 shares of the company’s stock worth $11,465,000 after purchasing an additional 60,427 shares during the last quarter. Synovus Financial Corp raised its stake in shares of Clorox by 14.5% during the second quarter. Synovus Financial Corp now owns 8,786 shares of the company’s stock worth $1,173,000 after purchasing an additional 1,114 shares during the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in shares of Clorox during the second quarter worth approximately $2,184,000. Ameriprise Financial Inc. raised its stake in shares of Clorox by 24.6% during the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after purchasing an additional 265,200 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its stake in shares of Clorox by 3.2% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 44,974 shares of the company’s stock worth $5,992,000 after purchasing an additional 1,399 shares during the last quarter. Institutional investors and hedge funds own 73.42% of the company’s stock.
Clorox Company (CLX) traded down $0.18 during trading hours on Tuesday, reaching $145.05. The company’s stock had a trading volume of 738,100 shares, compared to its average volume of 817,092. The stock has a market capitalization of $18,725.75, a PE ratio of 26.17, a price-to-earnings-growth ratio of 3.95 and a beta of 0.43. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. Clorox Company has a 1 year low of $115.00 and a 1 year high of $145.32.
Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. Clorox’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.36 earnings per share. sell-side analysts anticipate that Clorox Company will post 5.6 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.32%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s payout ratio is 61.88%.
CLX has been the subject of several analyst reports. BMO Capital Markets restated an “outperform” rating on shares of Clorox in a research note on Tuesday, September 12th. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Jefferies Group restated a “hold” rating and set a $132.00 price target (down previously from $137.00) on shares of Clorox in a research note on Friday, October 6th. Royal Bank of Canada restated a “hold” rating and set a $115.00 price target on shares of Clorox in a research note on Sunday, October 8th. Finally, Morgan Stanley cut their price objective on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research report on Thursday, November 2nd. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $128.72.
In other Clorox news, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Chevy Chase Trust Holdings Inc. Raises Holdings in Clorox Company (The) (CLX)” was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://transcriptdaily.com/2017/12/12/chevy-chase-trust-holdings-inc-raises-holdings-in-clorox-company-the-clx.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.